ClinicalTrials.Veeva

Menu

Prevalence of IR in Overweight and Obese Adolescents

A

Assiut University

Status

Not yet enrolling

Conditions

Insulin Resistance

Treatments

Diagnostic Test: Blood Tests; Serum Fasting Insulin and Glucose

Study type

Observational

Funder types

Other

Identifiers

NCT05810883
IR in Overweight Adolescents

Details and patient eligibility

About

The aim of this study is to determine the prevalence of Insulin Resistance (IR) among overweight and obese adolescents using HOMA-IR scores and identify lifestyle risk factors in the IR and Non-IR group.

Enrollment

50 estimated patients

Sex

All

Ages

10 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adolescents of ages ≥ 10-≤18 years, of both sexes who are Overweight (BMI > 85th percentile) or Obese (BMI > 95th percentile).

Exclusion criteria

  • Obesity due to Secondary causes as Cushing disease or hypothyroid patients, and any other patients with Chronic illness.

Trial design

50 participants in 2 patient groups

Insulin Resistant Group
Description:
HOMA-IR score of ≥ 3.4
Treatment:
Diagnostic Test: Blood Tests; Serum Fasting Insulin and Glucose
Non-Insulin Resistant
Description:
HOMA-IR score of less than 3.4
Treatment:
Diagnostic Test: Blood Tests; Serum Fasting Insulin and Glucose

Trial contacts and locations

0

Loading...

Central trial contact

Yara Mostafa, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems